Submitted by Anonymous (not verified) on 14 September 2026 - 15:00
Human medicines European public assessment report (EPAR): Zonisamide Viatris (previously Zonisamide Mylan), zonisamide, Date of authorisation: 31/03/2016, Revision: 14, Status: Authorised
Source: